AEON

0.12307.59%
MF

Marc Forth

Director

Mr. Marc Forth is President and Chief Executive Officer of Jeune Aesthetics, Inc. from April 7, 2025. Mr. Forth has also served as a valuable contributor on Jeune’s board of directors since February 2021. He was Chief Executive Officer of ABP Sub Inc. starting in May 2019. Mr. Forth served as Chief Executive Officer at AEON Biopharma, Inc., since December 2019 until April 04, 2025 and also served as its Principal Financial Officer since May 17, 2024 until April 04, 2025 and served as its President until April 04, 2025. Prior to AEON Biopharma, Mr. Forth was the Senior Vice President of Allergan PLC and Division Head for the U.S. Neurosciences, Urology and Medical Dermatology Division. During his 16 year tenure at Allergan, Mr. Forth was responsible for all aspects of the commercialization of both current and future products within Neurosciences, Urology and Medical Dermatology, most notably Botox for all therapeutic uses. Mr. Forth has held various leadership roles within Allergan since June 2003, including Vice President, Sales and Marketing Urology from February 2011 to February 2014 and Vice President, Specialty Therapeutics from July 2008 to February 2011. From June 2003 to July 2008, Mr. Forth also worked in various roles of increasing responsibility most notably focused on U.S. Aesthetics (Botox Cosmetic) and Global Strategic Marketing (Botox Therapeutic). Prior to Allergan, Mr. Forth held various Sales and Marketing roles of increasing responsibility at TAP Pharmaceutical Inc., a specialty company focused on Urology, Oncology, Gynecology and Gastroenterology. He has been Director of AEON Biopharma, Inc. since June 2023. Mr. Forth received a B.S. in Business Administration from California State University, Fresno and a Graduate Marketing Certification from Southern Methodist University.

Positions